Marino Andrea, Raddusa Michele Salvatore Paternò, Gussio Maria, Sangiorgio Giuseppe, Moscatt Vittoria, Libra Alessandro, Spampinato Serena, Bongiorno Dafne, Cacopardo Bruno, Nunnari Giuseppe
Department of Clinical and Experimental Medicine, ARNAS Garibaldi Hospital, Unit of Infectious Diseases, University of Catania, 95123 Catania, Italy.
Unit of Infectious Diseases, Department of Clinical and Experimental Medicine, University of Messina, 98124 Messina, Italy.
IDCases. 2024 Aug 24;37:e02067. doi: 10.1016/j.idcr.2024.e02067. eCollection 2024.
This study aims to assess the characteristics and treatment outcomes of patients diagnosed with non-tuberculous mycobacteria (NTM) diseases at the Infectious Diseases Unit of ARNAS Garibaldi Hospital in Catania, Italy, focusing on demographics, clinical features, and treatment effectiveness.
We conducted a retrospective observational study of 10 patients diagnosed with NTM diseases between 2019 and 2021. Data was collected from electronic medical records, including demographic information, comorbidities, treatment modalities, and outcomes. The study utilized descriptive statistics to analyze continuous and categorical variables. Treatment regimens were based on individual patient needs, incorporating a combination of antibiotics.
The median age of the patients was 55.44 years, all female, predominantly suffering from pulmonary NTM diseases. was the most common pathogen. Common comorbidities included COPD, bronchiectasis, GERD, and hypovitaminosis D. Patients showed symptoms like fever, cough, and asthenia. The treatment regimens were diverse, with macrolides, rifampicin, and ethambutol forming the core. Adverse effects were noted in 40 % of patients, including gastrointestinal and neurological disorders. All patients achieved microbiological cure, with 60 % showing clinical improvement and 36 % radiological improvement.
The study highlights the complexity of diagnosing and treating NTM diseases, emphasizing the need for personalized treatment plans and vigilant monitoring of adverse effects. Despite achieving microbiological cure, challenges remain in achieving complete clinical and radiological resolution. Further research is needed to enhance the understanding and management of NTM diseases, particularly in diverse populations.
本研究旨在评估意大利卡塔尼亚市ARNAS加里波第医院传染病科诊断为非结核分枝杆菌(NTM)疾病患者的特征和治疗结果,重点关注人口统计学、临床特征和治疗效果。
我们对2019年至2021年间诊断为NTM疾病的10例患者进行了回顾性观察研究。数据从电子病历中收集,包括人口统计学信息、合并症、治疗方式和结果。该研究采用描述性统计分析连续变量和分类变量。治疗方案根据个体患者需求制定,采用抗生素联合使用。
患者的中位年龄为55.44岁,均为女性,主要患有肺部NTM疾病。 是最常见的病原体。常见合并症包括慢性阻塞性肺疾病(COPD)、支气管扩张、胃食管反流病(GERD)和维生素D缺乏症。患者出现发热、咳嗽和乏力等症状。治疗方案多样,大环内酯类、利福平和乙胺丁醇为核心用药。40%的患者出现不良反应,包括胃肠道和神经系统疾病。所有患者均实现微生物学治愈,60%的患者有临床改善,36%的患者有影像学改善。
该研究突出了NTM疾病诊断和治疗的复杂性,强调了个性化治疗方案和对不良反应进行密切监测的必要性。尽管实现了微生物学治愈,但在实现完全临床和影像学缓解方面仍存在挑战。需要进一步研究以加强对NTM疾病的理解和管理,特别是在不同人群中。